Napa Wealth Management’s Boston Scientific BSX Stock Holding History

Napa Wealth Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-7,340	Closed	-$740K	–	137
2025 Q1	$740K	Buy	+7,340	New	+$739K	0.42%	60
2024 Q4	–	Sell	-27,392	Closed	-$2.3M	–	181
2024 Q3	$2.3M	Buy	+27,392	New	+$2.16M	1.09%	18

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Napa Wealth Management's BSX Position: Q2 2025 in Review

Napa Wealth Management sold out of Boston Scientific (BSX) in Q2 2025, closing a stake of 7,340 shares — an estimated $740K sold.

Napa Wealth Management first reported a position in BSX in Q3 2024 and held it in 2 quarters. The position peaked at $2.3M in Q3 2024. 1,688 funds tracked by Wall St. Rank hold BSX as of Q2 2025.

Napa Wealth Management reported no remaining Boston Scientific position as of Q2 2025 after selling out during the quarter.
Napa Wealth Management sold 7,340 Boston Scientific shares in Q2 2025, an estimated $740K.
Napa Wealth Management first reported a position in Boston Scientific in Q3 2024 and held it in 2 quarters.
Napa Wealth Management's Boston Scientific position peaked at $2.3M in Q3 2024.
1,688 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2025.

Based on Napa Wealth Management's 13F filing for Q2 2025, filed 14 Aug 2025.